CHMFL-ABL-039
CHMFL-ABL-039 is a type II native ABL kinase and drug-resistant V299L mutant BCR-ABL inhibitor (IC50s: 7.9 nM and 27.9 nM) used in the research of chronic myeloid leukemia.
Product Specifications
CAS Number
2304344-56-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
594.639
Molecular Formula
C31H33F3N6O3
Notes
Research use only, not for human use.
Receptor
Apoptosis| DUSP6
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog